Surgery in Practice and Science
Cautious clinical interpretation of preoperative Tc-99m-Sestamibi localization scan among chronic kidney disease and transplanted patients
By Orel Elhadad, Ran Fisher, Keren Tzukert and 3 others.
Abstract
Introduction Chronic kidney disease (CKD) patients and kidney transplant recipients are predisposed to developing hyperparathyroidism. Although CKD is typically associated with parathyroid hyperplasia, preoperative assessment may include a 99m Tc‑MIBI localization scan, performed selectively rather than routinely, which may demonstrate findings suggestive of a parathyroid adenoma. Diagnosing an adenoma potentially eliminates the need for four-gland exploration. However, the clinical meaning of pre-operative scans among renal patients remains unclear. The study objectives are: Determine adenoma and hyperplasia prevalence in the study population and the pre-operative MIBI scan localization outcomes. Identify potential predictors for either adenoma or hyperplasia. Materials and methods Retrospective cohort study, with at least 6 months post-operative follow-up, based on laboratory, imaging, medical, and operative notes in referral medical center between 2012 and 2022. Results Among 871 parathyroidectomies, 59 patients had a relevant renal background and long-term follow-up. Of these, 31 (53%) had hyperplasia. Preoperative 99m Tc-MIBI scan demonstrated positive localization for adenoma in 73% of patients. However, 22% were later diagnosed with hyperplasia (false positive), resulting in an effective localization rate of only 56.9%. The scan had 78.57% accuracy and positive and negative predictive values of 76.66% and 83.33%, respectively. Hyperplasia was significantly associated with younger age (p=0.009) and dialysis dependence (p=0.007). Hyperplasia was correlated with relative subtle hypercalcemia (p=0.015), significant higher phosphorus (p=0.001), higher alkaline phosphatase (p<0.001), and higher PTH levels (p=0.004). Discussion Over half of CKD patients had hyperplasia. The majority of patients underwent a localization parathyroid MIBI scan. About 3/4 of scanned patients had positive adenoma localization, but only 3/4 were eventually operated on and cured as adenoma. Conclusions We demonstrate a limited benefit of MIBI scans in CKD and kidney transplant patients. We recommend either omitting the scan or performing bilateral neck exploration or at least two same-side parathyroid glands exploration to improve cure rates.



